Three KIYATEC abstracts accepted for poster presentations during 2017 AACR Conference in Washington D.C.
KIYATEC, a private company prioritizing accurate ex vivo prediction of patients’ response to drug treatment, received acceptance of three posters for presentations during the upcoming AACR conference.
GREENVILLE, SC, March 21, 2017– KIYATEC Inc. is pleased to announce that three abstracts have been accepted by the committee at the American Association for Cancer Research (www.aacr.org). KIYATEC scientific and business development staff will be in attendance at the conference. In addition to the poster presentations, also KIYATEC will be exhibiting at Booth 1556. Stop by to learn more about our 10+ years of 3D cell culture experience and the latest 3D co-culture model development projects focused on immuno-oncology applications.
- Abstract #1923 / 24 – Paired isolation and expansion of CSC and CTC from primary small cell lung cancer patient tissue and blood using the 3DKUBE bioreactor platform | Monday Apr 3, 2017 8:00 AM – 12:00 PM | Location: Section 41 / Poster 24 (LINK)
- Abstract #4834 / 24 – 3D modeling of immune cell interactions in breast cancer and prediction of immunotherapy response | Tuesday,
Apr 4, 2017, 1:00 PM – 5:00 PM | Location: Section 39 / Poster 24 (LINK)
- Abstract #4837 / 27 – Development of an in vitro 3D glioblastoma model system for patient-specific drug response profiling | Tuesday,
Apr 4, 2017 1:00 PM – 5:00 PM | Location: Section 39 / Poster 27 (LINK)